Arguments For New Chantix MDL To Be Heard Dec. 1 By Judicial Panel

Mealey's (October 18, 2022, 3:56 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) will hear arguments Dec. 1 on whether to centralize eight federal lawsuits alleging that the smoking cessation drug Chantix was contaminated with nitrosamines, a potentially cancer-causing chemical....